Netherlands
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Netherlands (NL)
2000 | 415.9 thousand |
2011 | 881.6 thousand |
2024 | 895.7 thousand |
2050 | 896.2 thousand |
Netherlands is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- Ministry of Health, Netherlands, POLS Health Interview Survey, Statistics Netherlands, 2010
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 415.9 | 881.6 | 895.7 | 896.2 |
Age-standardised prevalence of diabetes, % | - | 5.3 | 5.0 | 5.9 |
Proportion of people with undiagnosed diabetes, % | - | - | 28.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 255.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 839.6 | 821.6 |
Age-standardised prevalence of IFG, % | - | - | 5.5 | 6.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 1,143.3 | 693.3 | 685.6 |
Age-standardised prevalence of IGT, % | - | 7.5 | 4.3 | 4.8 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 7,054.0 | 8,574.6 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 11.8 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 5,585.3 | 5,097.9 |
Total diabetes-related health expenditure, ID million | - | - | 5,930.6 | 5,413.0 |
Diabetes-related health expenditure per person, USD | - | 6,119.0 | 6,235.4 | 5,688.5 |
Diabetes-related health expenditure per person, ID | - | - | 6,620.8 | 6,040.1 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 66,784.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 6,913.4 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 11,494.0 | 12,059.2 | 13,074.9 | 12,484.8 |
Population of children and adolescents (0-19 y) | - | - | 3,753,655.5 | - |
Loading...
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 415.9 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 11,494.0 |
Population of children and adolescents (0-19 y) | - |